Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response
David N. Taylor, John J. Treanor, Eric A. Sheldon, Casey Johnson, Scott Umlauf, Langzhou Song, Uma Kavita, Ge Liu, Lynda Tussey, Karen Ozer, Thomas Hofstaetter, Alan Shaw
Dive into the research topics of 'Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response'. Together they form a unique fingerprint.